EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.267
https://www.valueinhealthjournal.com/article/S1098-3015(22)02471-8/fulltext
Title : EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02471-8&doi=10.1016/j.jval.2022.09.267
First page :
Section Title :
Open access? : No
Section Order : 12069
Categories :
Tags :
Regions :
ViH Article Tags :